Cargando…

Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease

[Figure: see text]

Detalles Bibliográficos
Autores principales:	Mensah, George A., Vaduganathan, Muthiah, Roth, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	by the American College of Cardiology Foundation. Published by Elsevier. 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901496/ https://www.ncbi.nlm.nih.gov/pubmed/36754517 http://dx.doi.org/10.1016/j.jacc.2022.11.042

Ejemplares similares

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review
por: Roth, Gregory A., et al.
Publicado: (2022)

Closer to FREEDOM From Uncertainty
por: Vaduganathan, Muthiah, et al.
Publicado: (2023)

Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes
por: Desai, Rishi J., et al.
Publicado: (2020)

Temporal Trends in Heart Failure Incidence Among Medicare Beneficiaries Across Risk Factor Strata, 2011 to 2016
por: Khera, Rohan, et al.
Publicado: (2020)

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone
por: Agarwal, Rajiv, et al.
Publicado: (2023)

Reply: Are We Missing Something in the Management of Acute Coronary Syndromes in COVID-19-Negative Patients?
por: Bhatt, Ankeet S., et al.
Publicado: (2020)

Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
por: Lam, Carolyn S. P., et al.
Publicado: (2021)

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
por: Essien, Utibe R., et al.
Publicado: (2023)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries
por: Sumarsono, Andrew, et al.
Publicado: (2020)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
por: Leiva, Orly, et al.
Publicado: (2020)

Regulation of Cardiovascular Therapies During the COVID-19 Public Health Emergency
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States
por: Vaduganathan, Muthiah, et al.
Publicado: (2021)

Multi-marker risk assessment in patients hospitalized with COVID-19: Results from the American Heart Association COVID-19 Cardiovascular Disease Registry
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Fewer Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic
por: Bhatt, Ankeet S., et al.
Publicado: (2020)

Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis
por: Varshney, Anubodh S., et al.
Publicado: (2021)

Patient characteristics and acute cardiovascular event rates among patients with very high‐risk and non‐very high‐risk atherosclerotic cardiovascular disease
por: Fonarow, Gregg C., et al.
Publicado: (2021)

Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
por: Suthahar, Navin, et al.
Publicado: (2020)

Physician Practice Pattern Variations in Common Clinical Scenarios Within 5 US Metropolitan Areas
por: Song, Zirui, et al.
Publicado: (2022)

Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial
por: Jhund, Pardeep S., et al.
Publicado: (2023)

Association Between Risk Factors for Complications From COVID-19, Perceived Chances of Infection and Complications, and Protective Behavior in the US
por: Schoeni, Robert F., et al.
Publicado: (2021)

Risk assessment in COVID‐19: Prognostic importance of cardiovascular parameters
por: Zdanyte, Monika, et al.
Publicado: (2022)

Association of colchicine use for acute gout with clinical outcomes in acute decompensated heart failure
por: Roth, Mary E., et al.
Publicado: (2022)

Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER
por: Desai, Akshay S., et al.
Publicado: (2022)

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14
por: Pratley, Richard E., et al.
Publicado: (2019)

Operational challenges and mitigation measures during the COVID-19 pandemic–Lessons from DELIVER
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306
por: Segar, Matthew W., et al.
Publicado: (2020)

Acute cardiovascular hospitalizations and illness severity before and during the COVID‐19 pandemic
por: Rao, Vishal N., et al.
Publicado: (2021)

Extensive Arterial Thrombosis in Covid-19
por: Merz, Lauren E., et al.
Publicado: (2020)

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic
por: HALL, MICHAEL E., et al.
Publicado: (2020)

Cardiovascular disease risk profile and microvascular complications of diabetes: comparison of Indigenous cohorts with diabetes in Australia and Canada
por: Maple-Brown, Louise J, et al.
Publicado: (2012)

Association of the New Peer Group–Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program
por: McCarthy, Cian P., et al.
Publicado: (2019)

Comorbidities and cardiovascular risk factors in patients with psoriasis
por: Baeta, Isabela Guimarães Ribeiro, et al.
Publicado: (2014)

Effect of Growth Under Selection on Appearance of Chromosomal Mutations in Salmonella enterica
por: Quiñones-Soto, Semarhy, et al.
Publicado: (2011)

Investigating the Association Between Telemedicine Use and Timely Follow-Up Care After Acute Cardiovascular Hospital Encounters
por: Tang, Mitchell, et al.
Publicado: (2022)

Development of a positive psychology intervention for patients with acute cardiovascular disease
por: Huffman, Jeff C., et al.
Publicado: (2011)

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk
por: Böhm, Michael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hs3on23pmovubdo663opvmeug6